Skip to content

Retrospective analysis of prognosis in sentinel node-positive breast cancer patients who received no axillary lymph node dissection

Retrospective analysis of prognosis in sentinel node-positive breast cancer patients who received no axillary lymph node dissection - Prognosis in sentinel node-positive breast cancer patients who received no axillary lymph node dissection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016888
Enrollment
200
Registered
2015-03-30
Start date
2015-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Group study at the Japanese Breast Cancer Society in 2014
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Surgical treatment between 2008 and 2011 2) T1-3 N0 M0 3) Invasive carcinoma proven by histological examination 4) 1-3 micrometastases and/or macrometastases in sentinel nodes 5) No axillary lymph node dissection

Exclusion criteria

Exclusion criteria: 1) Non-invasive carcinoma of the breast 2) T4N1 or more advanced, or M1 3) Sentinel nodes with no metastases or isolated tumor cells 4) Synchronous or metachronous bilateral breast cancer 5) Cases with pregnancy or lactating breast 6) Cases with drug therapy or radiation therapy before sentinel node biopsy

Design outcomes

Primary

MeasureTime frame
regional node recurrence and overall survival rate after 5 years of sentinel node biopsy

Countries

Japan

Contacts

Public ContactKazumi Takano

School of Medicine, Kyorin University Department of Breast Surgery

k-takano@ks.kyorin-u.ac.jp0422-47-6273

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026